Are plasma homocysteine and methionine elevated when binging and purging behavior complicates anorexia nervosa? Evidence against the transdiagnostic theory of eating disorders

Eating and Weight Disorders

Volumn 14, Issue 4, 2009, Pages

  Innis, S M ^a   Birmingham, C Laird ^a,b   Harbottle, E J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amino acids; Anorexia nervosa; Eating disorders; Homocysteine; Methionine

Indexed keywords

HOMOCYSTEINE; METHIONINE; MONOAMINE;

ADULT; AMINO ACID BLOOD LEVEL; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; BODY MASS; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EATING DISORDER; FEMALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METHIONINE BLOOD LEVEL; MONOAMINE METABOLISM; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 77949482449     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03325115     Document Type: Article

References (54)

1. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC, American Psychiatric Association, 2000.
2. Davis C.: Eating disorders and hyperactivity: a psychobiological perspective. Can. J. Psychiatry, 42, 168-175, 1997.
3. Birmingham C.L., Gutierrez E., Jonat L., Beumont P.: Randomized controlled trial of warming in anorexia nervosa. Int. J. Eat. Disord., 35, 234-238, 2004.
4. Kas M.J., Kaye W.H., Foulds Mathes W., Bulik C.M.: Interspecies genetics of eating disorder traits. Am. J. Med. Genet. B Neuropsychiatr. Genet., 150, 318-327, 2009.
5. Birmingham C.L., Gritzner S.: How does zinc supplementation benefit anorexia nervosa? Eat. Weight Disord., 11, e109-e111, 2006.
6. Fetissov S.O., Dechelotte P.: The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr. Opin. Clin. Nutr. Metab. Care, 11, 428-434, 2008.
7. Cleveland M.J., Feinberg M.E., Bontempo D.E., Greenberg M.T.: The role of risk and protective factors in substance use across adolescence. J. Adolesc. Health, 43, 157-164, 2008.
8. McNally L., Bhagwagar Z., Hannestad J.: Inflammation, glutamate, and glia in depression: a literature review. C.N.S. Spectr., 13, 501-510, 2008.
9. Bowie D.: Ionotropic glutamate receptors & CNS disorders. C.N.S. Neurol. Disord. Drug Targets, 7, 129-143, 2008.
10. Kaye W.: Neurobiology of anorexia and bulimia nervosa. Physiol. Behav., 94, 121-135, 2008.
11. Finkelstein J.D.: Methionine metabolism in mammals. J. Nutr. Biochem., 1, 228-237, 1990.
12. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., Scott J.M.: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem., 50, 3-32, 2004.
13. Refsum H., Ueland P.M., Nygard O., Vollset S.E.: Homocysteine and cardiovascular disease. Annu. Rev. Med., 49, 31-62, 1998.
14. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G.: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J.A.M.A., 274, 1049-1057, 1995.
15. McCully K.S.: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol., 56, 111-128, 1969.
16. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., Tishler P.V., Hennekens C.H.: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J.A.M.A., 268, 877-881, 1992.
17. Wilcken D.E., Wilcken B.: The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest., 57, 1079-1082, 1976.
18. Israelsson B., Brattstrom L.E., Hultberg B.L.: Homocysteine and myocardial infarction. Atherosclerosis, 71, 227-233, 1988.
19. Ubbink J.B., Vermaak W.J., Bennett J.M., Becker P.J., van Staden D.A., Bissbort S.: The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin. Wochenschr., 69, 527-534, 1991.
20. Olszewski A.J., Szostak W.B.: Homocysteine content of plasma proteins in ischemic heart disease. Atherosclerosis, 69, 109-113, 1988.
21. Blasco C., Caballeria J., Deulofeu R., Lligona A., Pares A., Lluis J.M., Gual A., Rodes J.: Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. Alcohol Clin. Exp. Res., 29, 1044-1048, 2005.
22. Bleich S., Degner D., Javaheripour K., Kurth C., Kornhuber J.: Homocysteine and alcoholism. J. Neural. Transm. Suppl., 187-196, 2000.
23. Bleich S., Degner D., Wiltfang J., Maler J.M., Niedmann P., Cohrs S., Mangholz A., Porzig J., Sprung R., Ruther E., Kornhuber J.: Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol, 35, 351-354, 2000.
24. Carmel R., James S.J.: Alcohol abuse: an important cause of severe hyperhomocysteinemia. Nutr. Rev., 60, 215-221, 2002.
25. Cravo M.L., Gloria L.M., Selhub J., Nadeau M.R., Camilo M.E., Resende M.P., Cardoso J.N., Leitao C.N., Mira F.C.: Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr, 63, 220-224, 1996.
26. Halsted C.H., Villanueva J., Chandler C.J., Stabler S.P., Allen R.H., Muskhelishvili L., James S.J., Poirier L.: Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology, 23, 497-505, 1996.
27. Hultberg B., Berglund M., Andersson A., Frank A.: Elevated plasma homocysteine in alcoholics. Alcohol Clin. Exp. Res., 17, 687-689, 1993.
28. Zoccolella S., Simone I.L., Lamberti P., Samarelli V., Tortelli R., Serlenga L., Logroscino G.: Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology, 70, 222-225, 2008.
29. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M.: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol., 55, 1449-1455, 1998.
30. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A.: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med., 346, 476-483, 2002.
31. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., de Groot L.C., Hofman A., Witteman J.C., van Leeuwen J.P., Breteler M.M., Lips P., Pols H.A., Uitterlinden A.G.: Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med., 350, 2033-2041, 2004.
32. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., Broe K.E., Hannan M.T., Cupples L.A., Kiel D.P.: Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med., 350, 2042-2049, 2004.
33. Gjesdal C.G., Vollset S.E., Ueland P.M., Refsum H., Meyer H.E., Tell G.S.: Plasma homocysteine, folate, and vitamin B12 and the risk of hip fracture: the hordaland homocysteine study. J. Bone Miner. Res., 22, 747-756, 2007.
34. Bjelland I., Ueland P.M., Vollset S.E.: Folate and depression. Psychother. Psychosom., 72, 59-60, 2003.
35. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Yoon J.S.: Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br. J. Psychiatry, 192, 268-274, 2008.
36. Frieling H., Romer K., Roschke B., Bonsch D., Wilhelm J., Fiszer R., de Zwaan M., Jacoby G.E., Kornhuber J., Bleich S.: Homocysteine plasma levels are elevated in females with anorexia nervosa. J. Neural Transm., 112, 979-985, 2005.
37. Moyano D., Vilaseca M.A., Artuch R., Valls C., Lambruschini N.: Plasma total-homocysteine in anorexia nervosa. Eur. J. Clin. Nutr., 52, 172-175, 1998.
38. Vilaseca M.A., Moyano D., Artuch R., Ferrer I., Pineda M., Cardo E., Campistol J., Pavia C., Camacho J.A.: Selective screening for hyperhomocysteinemia in pediatric patients. Clin. Chem., 44, 662-664, 1998.
39. Frieling H., Romer K.D., Beyer S., Hillemacher T., Wilhelm J., Jacoby G.E., de Zwaan M., Kornhuber J., Bleich S.: Depressive symptoms may explain elevated plasma levels of homocysteine in females with eating disorders. J. Psychiatr. Res., 42, 83-86, 2008.
40. Striegel-Moore R.H., Wonderlich S.: Diagnosis and classification of eating disorders: Finding the way forward. Int. J. Eat. Disord., 40, S1 - S1, 2007.
41. Fairburn C.G., Cooper Z.: Thinking afresh about the classification of eating disorders. Int. J. Eat. Disord., 40, Suppl., S107-S110, 2007.
42. Fairburn C.G., Cooper Z., Shafran R.: Cognitive behaviour therapy for eating disorders: a "transdiagnostic" theory and treatment. Behav. Res. Ther., 41, 509-528, 2003.
43. Fairburn C.G., Harrison P.J.: Eating disorders. Lancet, 361, 407-416, 2003.
44. Hay P., Fairburn C.: The validity of the DSM-IV scheme for classifying bulimic eating disorders. Int. J. Eat. Disord., 23, 7-15, 1998.
45. Wade T.D., Bergin J.L., Martin N.G., Gillespie N.A., Fairburn C.G.: A transdiagnostic approach to understanding eating disorders. J. Nerv. Ment. Dis., 194, 510-517, 2006.
46. Innis S.M., Davidson A.G., Melynk S., James S.J.: Choline-related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis. Am. J. Clin. Nutr., 85, 702-708, 2007.
47. Friesen R.W., Novak E.M., Hasman D., Innis S.M.: Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J. Nutr., 137, 2641-2646, 2007.
48. Eikelboom J.W., Lonn E., Genest J., Jr., Hankey G., Yusuf S.: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med., 131, 363-375, 1999.
49. Hall R.C., Hoffman R.S., Beresford T.P., Wooley B., Hall A.K., Kubasak L.: Physical illness encountered in patients with eating disorders. Psychosomatics, 30, 174-191, 1989.
50. Birmingham C.L., Stigant C., Goldner E.M.: Chest pain in anorexia nervosa. Int. J. Eat. Disord., 25, 219-222, 1999.
51. O'Brien K.M., Vincent N.K.: Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clin. Psychol. Rev., 23, 57-74, 2003.
52. Birmingham C.L., Lear S.A., Kenyon J., Chan S.Y., Mancini G.B., Frohlich J.: Coronary atherosclerosis in anorexia nervosa. Int. J. Eat. Disord., 34, 375-377, 2003.
53. Miller A.L.: The methylation, neurotrasnmitter, and antioxidant connections between folate and depression. Altern. Med. Rev., 13, 216-226, 2008.
54. Bottiglier T.M.: Folate, B12, and neuropsychiatric disorders. Nutr. Rev., 54, 38-90, 1996.